Improved myocardial protection in the failing heart by selective endothelin-A receptor blockade

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 4, 2009, Pages

  Trescher, Karola ^a,b   Bauer, Michael ^b   Dietl, Wolfgang ^b   Hallström, Seth ^c   Wick, Nikolaus ^b   Wolfsberger, Margarita ^b   Ullrich, Robert ^b   Jürgens, Günther ^c   Wolner, Ernst ^b   Podesser, Bruno K ^a,b  

^a Department of Cardiac Surgery ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; TBC 3214NA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; HEART FAILURE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REPERFUSION INJURY;

EID: 62849083004     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.10.037     Document Type: Article

References (28)

1. Krämer B.K., Ittner K.P., Beyer M.E., Hoffmeister H.M., and Riegger G.A.J. Circulatory and myocardial effects of endothelin. J Mol Med 75 (1997) 886-890
2. Benigni A., and Remuzzi G. Endothelin antagonists. Lancet 353 (1999) 133-138
3. Pernow J., and Wang Q- D. Endothelin in myocardial ischaemia and reperfusion. Cardiovasc Res 33 (1997) 518-526
4. Hosada K., Nakao K., Arai H., Suga S., Ogawa Y., Mukoyama M., et al. Cloning and expression of human endothelin-1 receptor cDNA. FEBS Lett 287 (1991) 23-26
5. Ogawa Y., Nakao K., Arai H., Nakagawa O., Hosoda K., Suga S., et al. Molecular cloning of a non-isopeptideselective human endothelin receptor. Biochem Biophys Res Commun 178 (1991) 248-255
6. Hiramatsu T., Forbess J., Miura T., Roth S.J., Cioffi M.A., and Mayer J.E. Effects of endothelin-1 and endothelin-A recptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts. Circulation 92 (1995) 400-404
7. Goodwin A.T., Amrani M., Gray C.C., Chester A.H., and Yacoub M.H. Inhibition of endogenous endothelin during cardioplegia improves low coronary reflow following prolonged hypothermic arrest. Eur J Cardiothorac Surg 11 (1997) 981-987
8. Li X.-S., Wang Q.-D., and Pernow J. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischemia reperfusion in the rat. Eur J Pharmacol 283 (1995) 161-168
9. Brunner F., and Opie L.H. Role of endothelin-A receptors in ischemic contracture and reperfusion injury. Circulation 97 (1998) 391-398
10. Ozdemir R., Parlakpinar H., Polat A., Colak C., Ermis N., and Acet A. Selective endothelin a receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury. Toxicology 219 (2006) 142-149
11. Trescher K., Bernecker O., Fellner B., Semsroth S., Ullrich R., de Martin R., et al. Adenovirus-mediated overexpression of inhibitor kappa B-alpha attenuates postinfarct remodeling in the rat heart. Eur J Cardiothorac Surg 26 (2004) 960-967
12. Podesser B.K., Hallstroem S., Schima H., Huber L., Weisser J., Kröner A., et al. The erythrocyte perfused "working heart" model: hemodynamic and metabolic performance in comparison to crystalloid perfused hearts. J Pharmacol Toxicol Methods 41 (1999) 9-15
13. Trescher K., Bernecker O., Fellner B., Gyongyosi M., Schäfer R., Aharinejad S., et al. Inflammation and postinfarct remodeling: overexpression of IkappaB prevents ventricular dilation via increasing TIMP levels. Cardiovasc Res 69 (2006) 746-754
14. Korn P., Kröner A., Schirnhofer J., Hallström S., Bernecker O., Mallinger R., et al. Quinaprilat during cardioplegic arrest in the rabbit heart to prevent ischemia-reprfusion injury. J Thorac Cardiovasc Surg 124 (2002) 352-360
15. Dworschak M., Franz M., Hallström S., Semsroth S., Gasser H., Haisjackl M., et al. S-nitroso human serum albumin improves oxygen metabolism during reperfusion after severe myocardial ischemia. Pharmacology 72 (2004) 106-112
16. Hallström S., Gasser H., Neumayer C., Fügl A., Nanobashvili J., Jakubowski A., et al. S-Nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation 105 (2002) 3032-3038
17. Schaper J., Mulch J., Winkler B., and Schaper W. Ultrastructural, functional and biochemical criteria for estimation of reversibility of ischemic injury: a study on the effects of global ischemia on the isolated dog heart. J Mol Cell Cardiol 11 (1979) 521-541
18. Gonon A.T., Gourine A.V., and Pernow J. Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production. J Cardiovasc Pharmacol 36 (2000) 405-412
19. Gourine A.V., Gonon A.T., and Pernow J. Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia reperfusion. Am J Physiol Heart Circ Physiol 280 (2001) H1105-H1112
20. Gonon A.T., Erbas D., Bröijersen A., Valen G., and Pernow J. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 286 (2004) 1767-1774
21. Wang Q.D., Li X.S., and Pernow J. The nonpeptide endothelin receptor antagonist bosentan enhances myocardial recovery and endothelial function during reperfusion of the ischemic rat heart. J Cardiovasc Pharmacol 26 (1995) S445-S447
22. Matoba S., Tasumi T., Keira N., Kawahara A., Akashi K., Kobara M., et al. Cardioprotective effect of ACE inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes. Circulation 99 (1999) 817-822
23. Kitakaze M., Minamino T., Node K., Komamura K., Shinozaki Y., Mori H., et al. Beneficial effects of inhibition of ACE on ischemic myocardium during coronary hypoperfusion in dogs. Circulation 92 (1995) 950-961
24. Podesser B.K., Schirnhofer J., Bernecker O.Y., Kröner A., Franz M., Semsroth S., et al. Optimizing ischemia/reperfusion in the failing rat heart-improved myocardial protection with acute ACE inhibition. Circulation 106 (2002) 277-283
25. Sakai S., Miyauchi T., Kobayashi M., Yamaguchi I., Goto K., and Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384 (1996) 353-355
26. Podesser B.K., Siwik D.A., Eberli F.R., Sam F., Ngoy S., Lambert J., et al. ETA-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat. Am J Physiol Heart Circ Physiol 280 (2001) 984-991
27. Hu K., Gaudron P., Schmidt T.J., Hoffmann K.D., and Ertl G. Aggravation of left ventricular remodeling by a novel specific endothelin ET (A) antagonist EMD 94246 in rats with experimental myocardial infarction. J Cardiovasc Pharmacol 32 (1998) 505-508
28. Nguyen Q.T., Cernacek P., Calderoni A., Stewart D.J., Picard P., Sirois P., et al. Endothelin A receptor blockade causes adverse LV remodeling but improves pulmonary artery pressure after infarction in the rat. Circulation 98 (1998) 2323-2330